Coexistence of rheumatoid arthritis and a monoclonal CD4 T cell lymphoproliferative disorder
Handel, M.L.; Dodds, A.J.; Cohen, M.L.
Journal of Rheumatology 17(1): 84-85
1990
ISSN/ISBN: 0315-162X PMID: 2313679 Document Number: 356505
A 33-year-old man developed seropositive rheumatoid arthritis (RA) followed soon after by a monoclonal lymphoproliferative disorder characterized by CD4 positive T lymphocytes in his peripheral blood, bone marrow and lymph nodes. Previous reports of polyarthritis in association with a T cell lymphoproliferative disorder have all involved the CD8 phenotype.
Document emailed within 1 workday
Related Documents
Hall, S.; Ginsburg, W.W.; Vollertsen, R.S.; Hunder, G.G. 1983: The coexistence of rheumatoid arthritis and giant cell arteritis Journal of Rheumatology 10(6): 995-997Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Sugai, S.; Takiguchi, T.; Konda, S. 1984: Monoclonal immunoglobulins and B cell lymphoproliferative disorders Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 47(8): 1604-1615
Lioté, F.; Pertuiset, E.; Cochand-Priollet, B.; D'Agay, M.F.; Dombret, H.; Numéric, P.; D'Anglejan, G.; Kuntz, D. 1995: Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection Journal of Rheumatology 22(6): 1174-1178
Seegers, D.; Peña, A.S.; Bouma, G. 2004: The autoimmune lymphoproliferative syndrome: a disorder of programmed cell death Nederlands Tijdschrift Voor Geneeskunde 148(8): 371-376
Yasuda, S. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis Clinical Calcium 28(5): 668-676
Sawada, T.; Kanzaki, T.; Hashimoto, S.; Suzuki, A.; Yamada, R.; Odawara, M.; Yamamoto, K. 2009: Citrullinated antigens as C1q-binding and monoclonal rheumatoid factor (mRF)-binding peptides in synovial fluids from rheumatoid arthritis patients Clinical and Experimental Rheumatology 27(6): 989-992
Halla, J.T.; Volanakis, J.E.; Hardin, J.G.; Schrohenloher, R.E. 1978: Immune complex detection and complement activity in rheumatoid arthritis: a comparative study of a radioimmunoassay using monoclonal rheumatoid factor, gel diffusion techniques and C4 activity Clinical and Experimental Immunology 34(2): 226-234
Chen, K.Y.; Leslie, W.; Mahon, B.; Venugopal, P. 2011: A patient with necrobiotic xanthogranuloma presenting with an anterior mediastinal mass, plasma cell dyscrasia, and a lymphoproliferative disorder Clinical Advances in Hematology and Oncology: H&o 9(9): 696-700
Ishii, T.; Saeki, Y. 2002: Monoclonal antibody therapy for rheumatoid arthritis Nihon Rinsho. Japanese Journal of Clinical Medicine 60(3): 551-555
Kitani, A.; Hara, M.; Hirose, T.; Norioka, K.; Hirose, W.; Harigai, M.; Suzuki, K.; Kawagoe, M.; Shinmei, M.; Nakamura, H. 1987: Synovial fluids from patients with rheumatoid arthritis possessed B cell differentiation activity contributing to synthesis of rheumatoid factor in vitro Journal of Rheumatology 14(5): 873-879
Le Goff, P.; Youinou, P.; Hurez, D.; Renier, J.C.; Miossec, P.; Le Menn, G. 1982: Rheumatoid arthritis with monoclonal gammopathy. Retrospective review of twelve case-reports La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 58(16): 973-976
Nasonov, E.L. 2010: New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor) Terapevticheskii Arkhiv 82(5): 64-71
Barylak, A.; Kucharski, K.; Kozlowski, K. 1978: Unclassified hereditary connective tissue disorder or arrested juvenile rheumatoid arthritis in a 40 year old woman Australasian Radiology 22(4): 325-328
Hrncír, Z.; Tichý, M.; Chobola, M.; Herout, V. 1976: M component and monoclonal lambda light chains in the urine during screening for amyloidosis of the kidney in rheumatoid arthritis Vnitrni Lekarstvi 22(1): 84-89
Meijer, C.J.; de Graaff-Reitsma, C.B.; Lafeber, G.J.; Cats, A. 1982: In situ localization of lymphocyte subsets in synovial membranes of patients with rheumatoid arthritis with monoclonal antibodies Journal of Rheumatology 9(3): 359-365
Sundin, M.; Le Blanc, K.; Ringdén, O.; Barkholt, L.; Omazic, B.; Lergin, C.; Levitsky, V.; Remberger, M. 2006: The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation Haematologica 91(8): 1059-1067
Duke, O.; Panayi, G.S.; Janossy, G.; Poulter, L.W. 1982: An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies Clinical and Experimental Immunology 49(1): 22-30
Di Matteo, L.; D'Incecco, V.; Evangelista, L.; Castiglione, C.; Consoli, G. 1985: Evaluation of lymphocyte subpopulations using monoclonal antibodies in patients with rheumatoid arthritis undergoing treatment with a new gold salt (auranofin) Bollettino della Societa Italiana di Biologia Sperimentale 61(5): 777-781
Avdeev, A.S.; Novikov, A.A.; Aleksandrova, E.N.; Panasiuk, E.I.; Nasonov, E.L. 2014: The importance of cytokine profile characteristics for evaluating the therapeutic effectiveness of monoclonal antibodies against IL-6 receptors in patients with rheumatoid arthritis Klinicheskaia Meditsina 92(1): 28-34